Imatinib mesylate (STI571) enhances amrubicin-induced cytotoxic activity through inhibition of the phosphatidylinositol 3-kinase/Akt pathway in small cell lung cancer cells
2008 ◽
Vol 6
(12)
◽
pp. 138
Keyword(s):
2005 ◽
Vol 65
(18)
◽
pp. 8423-8432
◽
2005 ◽
Vol 11
(16)
◽
pp. 6065-6074
◽
2016 ◽
Vol 123
◽
pp. 317-331
◽
Keyword(s):
2014 ◽
Vol 21
(2)
◽
pp. 67-72
◽
Keyword(s):
Keyword(s):
Keyword(s):